Heart Rate Variability in a Progressive Heart Failure Model with Rapid Ventricular Pacing
DOI:
https://doi.org/10.1532/HSF98.20081058Abstract
Background: Heart rate variability (HRV) is an indicator of autonomic nervous system functionality and a recognized predictor of cardiac death; however, the changes in HRV occurring in progressive heart failure are not fully understood. The purpose of this study was to evaluate the progressive changes of autonomic system activity in progressive heart failure by rapid ventricular pacing in an animal model.
Methods: Heart failure was induced in 13 mongrel dogs (27.8 ± 3.7 kg) by rapid ventricular pacing (230 beats/min) for 4 weeks and maintenance of pacing at a reduced rate (190 beats/min) for 2 weeks. Time domain analysis and spectral analysis of HRV were performed with the MemCalc system after 30 minutes of pacing cessation every week. Hemodynamic and echocardiographic data were obtained before and after induction of heart failure.
Results: Cardiac output decreased significantly (3.6 L/min versus 1.6 L/min, P < .001) after 6 weeks of ventricular pacing. Significantly increased were the heart rate (126 beats/min versus 138 beats/min, P < .05), left ventricular end-diastolic pressure (9.1 mm Hg versus 30.9 mm Hg, P < .001), and pulmonary capillary wedge pressure (8.0 mm Hg versus 18.7 mm Hg, P < .001). High-frequency components progressively decreased. Low-frequency components progressively decreased except at 5 weeks after the pacing. A ratio of low- to high-frequency components increased in moderate heart failure and decreased in severe heart failure.
Conclusions: Changes in the high-frequency component and low-frequency component are important for assessing heart failure in progressive heart failure. Serial follow-up measurements of HRV might be helpful for patients with such disease.
References
Galinier M, Pathak A, Fourcade J, et al. 2000. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J21:475-82.nHoffmann J, Grimm W, Menz V, Müller HH, Maisch B. 2000. Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy. Heart83:531-8.nLampert R, Ickovics JR, Viscoli CJ, Horwitz RI, Lee FA. 2003. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. Am J Cardiol91:137-42.nLucreziotti S, Gavazzi A, Scelsi L, et al. 2000. Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. Am Heart J139:1088-95.nMotte S, Mathieu M, Brimioulle S, et al. 2005. Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol Heart Circ Physiol289:H1729-35.nArmstrong PW, Stopps TP, Ford SE, de Bold AJ. 1986. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation74:1075-84.nAronson D, Burger AJ. 2001. Effect of beta-blockade on heart rate variability in decompensated heart failure. Int J Cardiol79:31-9.nBinkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. 1991. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol18:464-72.nBullinga JR, Alharethi R, Schram MS, Birstow MR, Gilbert EM. 2005. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. J Card Fail11:693-9.nCasolo GC, Stroder P, Sulla A, Chelucci A, Freni A, Zerauschek M. 1995. Heart rate variability and functional severity of congestive heart failure secondary to coronary artery disease. Eur Heart J16:360-7.nCoumel P, Leenhardt A. 1991. Mental activity, adrenergic modulation, and cardiac arrhythmias in patients with heart disease. Circulation83 (4 Suppl):II58-70.nEaton GM, Cody RJ, Nunziata E, Binkley PF. 1995. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure. Circulation92:555-61.nIshise H, Asanoi H, Ishizaka S, et al. 1998. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol84:1234-41.nKanaya N, Hirata N, Kurosawa S, Nakayama M, Namiki A. 2003. Differential effects of propofol and sevoflurane on heart rate variability. Anesthesiology98:34-40.nKawasaki T, Azuma A, Sakatani T, et al. 2003. Prognostic value of heart rate variability in patients with hypertrophic cardiomyopathy. J Electrocardiol36:333-8.nNolan J, Batin PD, Andrews R, et al. 1998. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Circulation98:1510-6.nPetretta M, Spinelli L, Marciano F, et al. 2000. Effects of losartan treatment on cardiac autonomic control during volume loading in patients with DCM. Am J Physiol Heart Circ Physiol279:H86-92.nPonikowski P, Anker SD, Amadi A, et al. 1996. Heart rhythms, ventricular arrhythmias, and death in chronic heart failure. J Card Fail2:177-83.nPonikowski P, Anker SD, Chua TP, et al. 1997. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol79:1645-50.nScalvini S, Volterrani M, Zanelli E, et al. 1998. Is heart rate variability a reliable method to assess autonomic modulation in left ventricular dysfunction and heart failure? Assessment of autonomic modulation with heart rate variability. Int J Cardiol67:9-17.nSchwartz PJ, La Rovere MT, Vanoli E. 1992. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for postmyocardial infarction risk stratification. Circulation85 (1 Suppl):I77-91.nTakagaki M, McCarthy PM, Tabata T, et al. 2002. Induction and maintenance of an experimental model of severe cardiomyopathy with a novel protocol of rapid ventricular pacing. J Thorac Cardiovasc Surg123:544-9.nTakusagawa M, Komori S, Umetani K, et al. 1999. Alterations of autonomic nervous activity in recurrence of variant angina. Heart82:75-81.n
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).
